UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
FOX 9 Minneapolis-St. Paul on MSN21h
FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback